84
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluating the Impact of Interventions and Improvements in Outpatient Intravenous Infusion Therapy at a Hospital in China: A Comprehensive Analysis of Prescription Patterns and Safety Measures

, , &
Pages 525-533 | Received 23 Nov 2023, Accepted 22 Feb 2024, Published online: 07 Mar 2024

References

  • Yuan S. China should reduce the overuse of intravenous infusion. BMJ. 2014;348:g1262. PMID: 24495923. doi:10.1136/bmj.g1262
  • Zhang Z, Hu Y, Zou G, et al. Antibiotic prescribing for upper respiratory infections among children in rural China: a cross-sectional study of outpatient prescriptions. Glob Health Action. 2017;10(1):1287334. PMID: 28462635. doi:10.1080/16549716.2017.1287334
  • Lan MJ, Yao DF, Zhu LL, et al. The rate of infusion represents an important aspect of administering anticancer agents. Risk Manag Healthc Policy. 2023;16:2531–2541. PMID: 38024501. doi:10.2147/RMHP.S442692
  • Zeng S, Wang D, Liu W, et al. Overuse of intravenous infusions in China: focusing on management platform and cultural problems. Int J Clin Pharm. 2019;41(5):1133–1137. PMID: 31468253. doi:10.1007/s11096-019-00898-0
  • National adverse drug reaction monitoring annual report; 2020. Available from: https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/gzwj/gzwjyp/20210325170127199.html?ivk_sa=1024320u. Accessed March 26, 2021.
  • Yao JJ, Jurgensmeier K, Woodhead BM, et al. The use and adverse effects of oral and intravenous antibiotic administration for suspected infection after revision shoulder arthroplasty. J Bone Joint Surg Am. 2020;102(11):961–970. PMID: 32079886. doi:10.2106/JBJS.19.00846
  • Ternullo S. Acetadote (intravenous acetylcysteine): adverse effects more significant than with oral acetylcysteine. J Emerg Nurs. 2006;32(1):98–100. PMID: 16439302. doi:10.1016/j.jen.2005.09.015
  • Sasijareonrat N, Jahn N, Ungprasert P, et al. Efficacy and the adverse effects of oral versus intravenous arsenic for acute promyelocytic leukemia: a meta-analysis of randomized-controlled studies. Technol Cancer Res Treat. 2020;19:1533033820937008. PMID: 32583728. doi:10.1177/1533033820937008
  • Zeng S, Wang D, Yan Y, et al. Single-center analysis of the potential inappropriate use of intravenous medications in hospitalized patients in China. Clin Ther. 2019;41(8):1631–1637.e4. PMID: 31174860. doi:10.1016/j.clinthera.2019.05.009
  • Wang X, Wu D, Xuan Z, et al. The influence of a ban on outpatient intravenous antibiotic therapy among the secondary and tertiary hospitals in China. BMC Public Health. 2020;20(1):1794. PMID: 33239002. doi:10.1186/s12889-020-09948-z
  • The notice on strengthening the management of intravenous infusion in medical institutions. Available from: http://www.yingquan.gov.cn/xxgk/detail/content/549254837f8b9a9a2e349d5f.html. Accessed October 27, 2020.
  • Notice on issuing the national medical quality and safety improvement goals for 2021. Available from: http://www.nhc.gov.cn/yzygj/s7657/202102/8c53313663284a7ba146648509538ee2.shtml. Accessed October 7, 2021.
  • Sakamoto D, Hamaguchi T, Nakayama Y, et al. Changes in motor paralysis involving upper extremities of outpatient chronic stroke patients from temporary rehabilitation interruption due to spread of COVID-19 infection: an observational study on pre- and post-survey data without a control group. PLoS One. 2021;16(12):e0260743. PMID: 34882736. doi:10.1371/journal.pone.0260743
  • Cho SK, Mattke S, Sheridan M, et al. Outpatient wound clinics during COVID-19 maintained quality but served fewer patients. J Am Med Dir Assoc. 2022;23(4):660–665.e5. PMID: 34861225. doi:10.1016/j.jamda.2021.11.001
  • Machado KLC, Rosa STD, Dobner S, et al. Warfarin anticoagulation in the Covid-19 pandemic: telephone-based management at a regional hematology outpatient center in Joinville, Brazil. Thromb Res. 2021;205:81–83. PMID: 34265606. doi:10.1016/j.thromres.2021.07.006
  • Knörr V, Dini L, Gunkel S, et al. Use of telemedicine in the outpatient sector during the COVID-19 pandemic: a cross-sectional survey of German physicians. BMC Prim Care. 2022;23(1):92. PMID: 35461212. doi:10.1186/s12875-022-01699-7
  • Belleudi V, Finocchietti M, Fortinguerra F, et al. Drug prescriptions in the outpatient management of COVID-19: evidence-based recommendations versus real practice. Front Pharmacol. 2022;13:825479. PMID: 35401220. doi:10.3389/fphar.2022.825479
  • Winglee K, Hill AN, Langer AJ, et al. Decrease in tuberculosis cases during COVID-19 pandemic as reflected by outpatient pharmacy data, United States, 2020. Emerg Infect Dis. 2022;28(4):820–827. PMID: 35318920. doi:10.3201/eid2804.212014
  • Pate J, Mooney J, Katz E, et al. Efficacy of outpatient infusion therapy in pediatric patients with postconcussive headaches. Childs Nerv Syst. 2022;38(1):103–108. PMID: 34671849. doi:10.1007/s00381-021-05383-6
  • Park J, You SB, Kim H, et al. Experience of nurses with intravenous fluid monitoring for patient safety: a qualitative descriptive study. Risk Manag Healthc Policy. 2022;15:1783–1793. PMID: 36171867. doi:10.2147/RMHP.S374563
  • Adegbite BR, Edoa JR, Schaumburg F, et al. Knowledge and perception on antimicrobial resistance and antibiotics prescribing attitude among physicians and nurses in Lambaréné region, Gabon: a call for setting-up an antimicrobial stewardship program. Antimicrob Resist Infect Control. 2022;11(1):44. PMID: 35241171. doi:10.1186/s13756-022-01079-x
  • Sannathimmappa MB, Nambiar V, Aravindakshan R. Antibiotics at the crossroads - Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? J Educ Health Promot. 2021;10:438. PMID: 35071644. doi:10.4103/jehp.jehp_557_21